Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34-56 Peptide

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Haanstra, Krista G ^a   Wubben, Jacqueline A M ^a   Jonker, Margreet ^a   Hart, Bert A 't ^a,b  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; ENCEPHALITOGENIC PROTEIN; FREUND ADJUVANT; MOG34-56 PEPTIDE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BRAIN DAMAGE; CD4+ CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXPERIMENTAL MODEL; HERPESVIRUS PAPIO; IMMUNIZATION; LYMPHOBLASTOID CELL; LYMPHOCRYPTOVIRUS; LYMPHOCYTE PROLIFERATION; MONONUCLEOSIS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; RHESUS MONKEY; T LYMPHOCYTE; WEIGHT REDUCTION;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIBODIES; B-LYMPHOCYTES; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CITRULLINE; COHORT STUDIES; ENCEPHALITIS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOGLOBULIN G; LYMPHOCRYPTOVIRUS; MACACA MULATTA; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDES; T-LYMPHOCYTES;

EID: 84881578448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071549     Document Type: Article

References (35)

1. Frohman EM, Racke MK, Raine CS, (2006) Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 354: 942-955.
2. Geurts JJ, Barkhof F, (2008) Grey matter pathology in multiple sclerosis. Lancet Neurol 7: 841-851.
3. Steinman L, (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302.
4. Sospedra M, Martin R, (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23: 683-747.
5. Lunemann JD, Munz C, (2009) EBV in MS: guilty by association? Trends in immunology 30: 243-248.
6. Ascherio A, Munger KL, (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61: 288-299.
7. Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B, (2004) Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291: 1875-1879.
8. Pohl D, Krone B, Rostasy K, Kahler E, Brunner E, et al. (2006) High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67: 2063-2065.
9. Lacoste V, Lavergne A, de Thoisy B, Pouliquen JF, Gessain A, (2010) Genetic diversity and molecular evolution of human and non-human primate Gammaherpesvirinae. Infect Genet Evol 10: 1-13.
10. Nash AA, Dutia BM, Stewart JP, Davison AJ, (2001) Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci 356: 569-579.
11. Wang F, Rivailler P, Rao P, Cho Y, (2001) Simian homologues of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 489-497.
12. Flano E, Woodland DL, Blackman MA, (2002) A mouse model for infectious mononucleosis. Immunol Res 25: 201-217.
13. Hayashi K, Teramoto N, Akagi T, (2002) Animal in vivo models of EBV-associated lymphoproliferative diseases: special references to rabbit models. Histol Histopathol 17: 1293-1310.
14. Jenson HB, Ench Y, Gao SJ, Rice K, Carey D, et al. (2000) Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans. J Infect Dis 181: 1462-1466.
15. Casiraghi C, Shanina I, Cho S, Freeman ML, Blackman MA, et al. (2012) Gammaherpesvirus latency accentuates EAE pathogenesis: relevance to Epstein-Barr virus and multiple sclerosis. PLoS Pathog 8: e1002715.
16. 't Hart BA, Bauer J, Brok HP, Amor S, (2005) Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme. J Neuroimmunol 168: 1-12.
17. Brok HP, Boven L, van Meurs M, Kerlero de Rosbo N, Celebi-Paul L, et al. (2007) The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys. J Neuroimmunol 182: 135-152.
18. Kap YS, Smith P, Jagessar SA, Remarque E, Blezer E, et al. (2008) Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. J Immunol 180: 1326-1337.
19. Jagessar SA, Kap YS, Heijmans N, van Driel N, van Straalen L, et al. (2010) Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant. J Neuropathol Exp Neurol 69: 372-385.
20. Heller M, Kieff E, (1981) Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio. J Virol 37: 821-826.
21. Moghaddam A, Koch J, Annis B, Wang F, (1998) Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus. J Virol 72: 3205-3212.
22. Voss G, Nick S, Stahl-Hennig C, Ritter K, Hunsmann G, (1992) Generation of macaque B lymphoblastoid cell lines with simian Epstein-Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. J Virol Methods 39: 185-195.
23. Carrillo-Vico A, Leech MD, Anderton SM, (2010) Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system. J Immunol 184: 2839-2846.
24. Oguz KK, Kurne A, Aksu AO, Karabulut E, Serdaroglu A, et al. (2009) Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis. AJNR Am J Neuroradiol 30: 716-721.
25. Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L, et al. (2004) Genetic content of wild-type human cytomegalovirus. J Gen Virol 85: 1301-1312.
26. Ohga S, Nomura A, Takada H, Hara T, (2002) Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol 44: 203-215.
27. Cohen JI, (2000) Epstein-Barr virus infection. N Engl J Med 343: 481-492.
28. Kostich M, Fire A, Fambrough DM, (2000) Identification and molecular-genetic characterization of a LAMP/CD68-like protein from Caenorhabditis elegans. J Cell Sci 113 (Pt 14): 2595-2606.
29. Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ, et al. (2006) Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129: 517-526.
30. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, et al. (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202: 673-685.
31. Jagessar SA, Heijmans N, Blezer EL, Bauer J, Blokhuis JH, et al. (2012) Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant. Eur J Immunol 42: 217-227.
32. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC, (2003) NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends in immunology 24: 136-143.
33. Mazzarino P, Pietra G, Vacca P, Falco M, Colau D, et al. (2005) Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur J Immunol 35: 3240-3247.
34. van Leeuwen EM, de Bree GJ, ten Berge IJ, van Lier RA, (2006) Human virus-specific CD8+ T cells: diversity specialists. Immunol Rev 211: 225-235.
35. Jagessar AS, Fagrouch Z, Heijmans N, Bauer J, Laman JD, et al. (2013) The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model. J Neuroimmune Pharmacol.